LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

LLY

885.5

-2.24%↓

JNJ

241.6

+0.78%↑

ABBV

211.13

+1.25%↑

NVS

149.12

-1.12%↓

MRK

119.67

-0.08%↓

Search

Smith & Nephew PLC ADR

Открыт

31.76 -2.13

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

31.8

Макс.

32.59

Ключевые показатели

By Trading Economics

Доход

35M

331M

Продажи

203M

3.2B

P/E

Средняя по отрасли

22.336

57.05

Дивидендная доходность

2.45

Рентабельность продаж

10.368

Сотрудники

16,988

EBITDA

133M

856M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+7.73% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.45%

2.52%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.6B

14B

Предыдущая цена открытия

33.89

Предыдущая цена закрытия

31.76

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

26 мар. 2026 г., 23:43 UTC

Обсуждения рынка

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26 мар. 2026 г., 23:36 UTC

Обсуждения рынка
Главные новостные события

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26 мар. 2026 г., 23:35 UTC

Приобретения, слияния, поглощения

Pernod Ricard: Confirms Discussions With Brown-Forman

26 мар. 2026 г., 23:29 UTC

Отчет

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26 мар. 2026 г., 23:28 UTC

Отчет

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26 мар. 2026 г., 23:28 UTC

Отчет

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26 мар. 2026 г., 23:28 UTC

Отчет

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26 мар. 2026 г., 23:27 UTC

Отчет

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26 мар. 2026 г., 23:27 UTC

Отчет

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26 мар. 2026 г., 23:08 UTC

Обсуждения рынка

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26 мар. 2026 г., 23:04 UTC

Приобретения, слияния, поглощения

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26 мар. 2026 г., 23:04 UTC

Приобретения, слияния, поглощения

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26 мар. 2026 г., 23:04 UTC

Приобретения, слияния, поглощения

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26 мар. 2026 г., 23:04 UTC

Приобретения, слияния, поглощения

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26 мар. 2026 г., 23:04 UTC

Приобретения, слияния, поглощения

Pernod in Deal Talks With Brown-Forman -- WSJ

26 мар. 2026 г., 22:41 UTC

Приобретения, слияния, поглощения

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26 мар. 2026 г., 22:41 UTC

Приобретения, слияния, поглощения

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26 мар. 2026 г., 22:26 UTC

Отчет

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26 мар. 2026 г., 22:26 UTC

Отчет

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26 мар. 2026 г., 22:26 UTC

Отчет

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26 мар. 2026 г., 22:08 UTC

Отчет

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26 мар. 2026 г., 22:08 UTC

Отчет

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26 мар. 2026 г., 22:08 UTC

Отчет

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26 мар. 2026 г., 22:07 UTC

Обсуждения рынка
Главные новостные события

Global Energy Roundup: Market Talk

26 мар. 2026 г., 22:07 UTC

Обсуждения рынка
Главные новостные события

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26 мар. 2026 г., 22:00 UTC

Отчет

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26 мар. 2026 г., 22:00 UTC

Отчет

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26 мар. 2026 г., 22:00 UTC

Отчет

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26 мар. 2026 г., 21:39 UTC

Приобретения, слияния, поглощения

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26 мар. 2026 г., 21:38 UTC

Приобретения, слияния, поглощения

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

7.73% рост

Прогноз на 12 месяцев

Средняя 34.96 USD  7.73%

Максимум 35 USD

Минимум 34.91 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat